New data has shown the best potential in Casdatives, an HIF-2A inhibitor, in patients with the metastatic kidney cancer

Last updated: February 15, 2025 11:00 pm

BARI

Published February 15, 2025

New data has shown the best potential in Casdatives, an HIF-2A inhibitor, in patients with the metastatic kidney cancer

Share This Article